Skip to content

Kinematics-Based Prediction of Chronic Pain After Combat-Related Extremity Trauma

CompletedNCT07432685
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

Combat-related extremity trauma frequently results in persistent pain, including neuropathic, residual limb, and phantom limb pain. The kinematics of injury-including energy level, direction of force, and dominant force components-may independently predict tissue deformation, nerve stress, and the transition from acute to chronic- pain. This prospective observational cohort study will assess whether kinematics-only variables predict chronic pain outcomes after combat-related upper and lower limb injuries. Pain outcomes will include pain intensity, pain extent (surface/area), neuropathic pain features, and mechanical pain sensitivity measured using von Frey filaments.

Study details

Official title
KIN-LIMB Protocol V1.0. KIN-LIMB: Kinematics-Based Prediction of Chronic Pain After Combat-Related Extremity Trauma
Conditions
Sponsor
Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans)
Start date
2026-03-12
Primary completion
2026-10-11
Sex
All
Age range
from 18 Years to 50 Years
Results posted
No results posted in this snapshot
Countries
Ukraine
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age ≥18 years * Combat-related extremity trauma involving upper and/or lower limbs * Blunt limb trauma * Penetrating limb injury (ballistic or shrapnel) * Blast-related limb injury * Hybrid injury (blast plus fragment) * тTraumatic amputation (partial or complete) * Baseline assessment performed within 72 hours of injury * Acute limb pain with Numeric Rating Scale (NRS) score ≥3 at baseline * Ability to provide informed consent * Ability to participate in follow-up assessments Exclusion Criteria: * Inability to complete follow-up assessments * Severe cognitive impairment preventing informed consent * Declines participation

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07432685